Evidence map›Paper›PMID 32895239›Full record

ArticleAnnals of the rheumatic diseases2022

Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco

Kimme L Hyrich, Milena Gianfrancesco, Pedro M Machado, Jinoos Yazdany, Philip C Robinson

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Annals of the rheumatic diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Kimme L HyrichCentre for Epidemiology Versus Arthritis, University of Manchester, Manchester, UK.
Milena GianfrancescoDepartment of Medicine, Division of Rheumatology, University of California, San Francisco, San Francisco, California, USA.
Pedro M MachadoMRC Centre for Neuromuscular Diseases, University College London, London, UK.ORCID http://orcid.org/0000-0002-8411-7972
Jinoos YazdanyMedicine/Rheumatology, University of California, San Francisco, California, USA.
Philip C RobinsonFaculty of Medicine, The University of Queensland, Herston, Queensland, Australia philip.robinson@uq.edu.au.ORCID http://orcid.org/0000-0002-3156-3418

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Musculoskeletal DiseasesPhysiciansRheumatic DiseasesRheumatologyGlucocorticoidsHospitalizationHumansRegistriesGlucocorticoidsautoimmunityglucocorticoidsinflammation

Identifiers

PMID32895239

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.